| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $546.10 | $10,922,014.98 | -0.9% | +0.4% | +4.8% | |
| May 5, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 25,000 | $21.63 | $540,745.27 | -2.0% | -15.6% | +9.3% | |
| May 4, 2023 | DHR Danaher Corp /de/ | Couchara Georgeann56 | SVP, Human Resources | Sell | 695 | $245.27 | $170,462.65 | -30.8% | +6.4% | +2.5% | |
| May 4, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,372 | $21.64 | $181,143.64 | -0.9% | -23.7% | +10.5% | |
| May 4, 2023 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 9,934 | $245.27 | $2,436,512.18 | -9.8% | +6.4% | +2.5% | |
| May 3, 2023 | BIO Bio-Rad Laboratories, Inc. | Schwartz Steven D | 10% Owner | Sell | 320 | $463.86 | $148,435.20 | -17.6% | -12.2% | -39.8% | |
| May 2, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,819 | $8.12 | $22,897.89 | -0.5% | +37.9% | +16.1% | |
| May 2, 2023 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 5,102 | $2.29 | $11,683.58 | -5.8% | +7.3% | -29.5% | |
| May 2, 2023 | NDRA Endra Life Sciences Inc. | Digiandomenico Anthony | Director | Buy | 83,333 | $1.20 | $99,999.60 | +436.3% | -27.1% | -83.1% | |
| May 1, 2023 | WST West Pharmaceutical Services Inc | Abraham Silji62 | SVP, Chief Technology Officer | Sell | 8,020 | $365.60 | $2,932,116.52 | -46.9% | +0.6% | -2.2% | |
| May 1, 2023 | DHR Danaher Corp /de/ | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | Sell | 500 | $242.19 | $121,096.40 | -6.2% | +5.5% | +2.0% | |
| May 1, 2023 | WST West Pharmaceutical Services Inc | Hofmann Thomas W | Director | Sell | 1,212 | $365.58 | $443,076.90 | -2.7% | +0.6% | -2.2% | |
| May 1, 2023 | WST West Pharmaceutical Services Inc | Favorite Annette F | Sr. VP &Chief Hr Officer | Sell | 13,012 | $365.81 | $4,759,932.78 | -20.9% | +0.6% | -2.2% | |
| May 1, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,000 | $63.78 | $63,780.00 | -1.1% | +53.8% | -6.4% | |
| Apr 26, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 2,015 | $0.29 | $582.33 | -3.5% | -21.2% | +18.4% | |
| Apr 25, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 31,648 | $221.83 | $7,020,475.84 | -0.5% | +18.6% | +90.9% | |
| Apr 25, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 31,648 | $221.83 | $7,020,475.84 | -0.5% | +18.6% | +90.9% | |
| Apr 24, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,552 | $54.70 | $84,900.83 | -1.2% | -11.7% | +71.8% | |
| Apr 24, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,574 | $54.51 | $140,319.33 | -0.6% | -11.7% | +71.8% | |
| Apr 24, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 333 | $54.33 | $18,091.33 | - | -11.7% | +71.8% | |
| Apr 24, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 796 | $54.58 | $43,441.74 | -0.2% | -11.7% | +71.8% | |
| Apr 20, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 5,338 | $0.31 | $1,658.52 | -2.6% | -20.1% | -3.2% | |
| Apr 14, 2023 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Director | Sell | 34,000 | $22.04 | $749,356.60 | -44.3% | +30.1% | -7.8% | |
| Apr 13, 2023 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 2,435 | $136.51 | $332,391.36 | -13.9% | -11.9% | -24.4% | |
| Apr 13, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,372 | $22.65 | $189,663.02 | -0.9% | -22.8% | -13.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.